Pacific Shuanglin Bio-pharmacy , Ltd. Goodwill

As of the most recent data (September 2026), 000403.SZ shows a goodwill of $2.5B. That compares with $2.6B in the prior-year period — down 3.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 000403.SZ's goodwill is now $2.5B (was $2.6B) — a 3.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Pacific Shuanglin Bio-pharmacy , Ltd. is outperforming or lagging.

Tracking 000403.SZ's goodwill over time shows whether Pacific Shuanglin Bio-pharmacy , Ltd. is scaling, shrinking, or reshaping that part of the business. The current reading is $2.5B That compares with $2.6B in the prior-year period — down 3.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this goodwill page, Stockcircle has Pacific Shuanglin Bio-pharmacy , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect goodwill (currently $2.5B) with ownership activity and broader fundamentals.

Pacific Shuanglin Bio-pharmacy , Ltd.'s goodwill is $2.5B; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.